Global Anti-Infective Ophthalmic Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
Ophthalmic anti-infectives are anti-infectives contained in a product formulated especially to be instilled or applied in the eye or eyes. Ophthalmic anti-infectives include eyedrops, gels or ointments. Anti-infectives are drugs that can either kill an infectious agent or inhibit it from spreading. Anti-infectives include antibiotics and antibacterials, antifungals, antivirals and antiprotozoals.
According to our (Global Info Research) latest study, the global Anti-Infective Ophthalmic market size was valued at USD 1510.6 million in 2022 and is forecast to a readjusted size of USD 1877.9 million by 2029 with a CAGR of 3.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Major manufacturers of anti-infective eye drugs include Novartis, Allergan, Valeant Pharmaceuticals, Santen Pharmaceutical, Lupin Pharmaceuticals, Apotex and Akorn.
This report is a detailed and comprehensive analysis for global Anti-Infective Ophthalmic market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Anti-Infective Ophthalmic market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Anti-Infective Ophthalmic market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Anti-Infective Ophthalmic market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (USD/Unit), 2018-2029
Global Anti-Infective Ophthalmic market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (USD/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-Infective Ophthalmic
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-Infective Ophthalmic market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alcon, AbbVie, Bausch Health, Santen Pharmaceutical and Lupin Pharmaceuticals, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Anti-Infective Ophthalmic market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Eyedrops
Gels
Ointments
Other
Market segment by Application
Hospital
Retail Pharmacy
Others
Major players covered
Alcon
AbbVie
Bausch Health
Santen Pharmaceutical
Lupin Pharmaceuticals
Apotex
Akorn
Johnson & Johnson
Thea pharmaceuticals
URSAPHARM
SIMILASAN
Jianfeng Group
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-Infective Ophthalmic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-Infective Ophthalmic, with price, sales, revenue and global market share of Anti-Infective Ophthalmic from 2018 to 2023.
Chapter 3, the Anti-Infective Ophthalmic competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-Infective Ophthalmic breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Anti-Infective Ophthalmic market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-Infective Ophthalmic.
Chapter 14 and 15, to describe Anti-Infective Ophthalmic sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
1.1 Product Overview and Scope of Anti-Infective Ophthalmic
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Anti-Infective Ophthalmic Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Eyedrops
1.3.3 Gels
1.3.4 Ointments
1.3.5 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Anti-Infective Ophthalmic Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Others
1.5 Global Anti-Infective Ophthalmic Market Size & Forecast
1.5.1 Global Anti-Infective Ophthalmic Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Anti-Infective Ophthalmic Sales Quantity (2018-2029)
1.5.3 Global Anti-Infective Ophthalmic Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Alcon
2.1.1 Alcon Details
2.1.2 Alcon Major Business
2.1.3 Alcon Anti-Infective Ophthalmic Product and Services
2.1.4 Alcon Anti-Infective Ophthalmic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Alcon Recent Developments/Updates
2.2 AbbVie
2.2.1 AbbVie Details
2.2.2 AbbVie Major Business
2.2.3 AbbVie Anti-Infective Ophthalmic Product and Services
2.2.4 AbbVie Anti-Infective Ophthalmic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 AbbVie Recent Developments/Updates
2.3 Bausch Health
2.3.1 Bausch Health Details
2.3.2 Bausch Health Major Business
2.3.3 Bausch Health Anti-Infective Ophthalmic Product and Services
2.3.4 Bausch Health Anti-Infective Ophthalmic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Bausch Health Recent Developments/Updates
2.4 Santen Pharmaceutical
2.4.1 Santen Pharmaceutical Details
2.4.2 Santen Pharmaceutical Major Business
2.4.3 Santen Pharmaceutical Anti-Infective Ophthalmic Product and Services
2.4.4 Santen Pharmaceutical Anti-Infective Ophthalmic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Santen Pharmaceutical Recent Developments/Updates
2.5 Lupin Pharmaceuticals
2.5.1 Lupin Pharmaceuticals Details
2.5.2 Lupin Pharmaceuticals Major Business
2.5.3 Lupin Pharmaceuticals Anti-Infective Ophthalmic Product and Services
2.5.4 Lupin Pharmaceuticals Anti-Infective Ophthalmic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Lupin Pharmaceuticals Recent Developments/Updates
2.6 Apotex
2.6.1 Apotex Details
2.6.2 Apotex Major Business
2.6.3 Apotex Anti-Infective Ophthalmic Product and Services
2.6.4 Apotex Anti-Infective Ophthalmic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Apotex Recent Developments/Updates
2.7 Akorn
2.7.1 Akorn Details
2.7.2 Akorn Major Business
2.7.3 Akorn Anti-Infective Ophthalmic Product and Services
2.7.4 Akorn Anti-Infective Ophthalmic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Akorn Recent Developments/Updates
2.8 Johnson & Johnson
2.8.1 Johnson & Johnson Details
2.8.2 Johnson & Johnson Major Business
2.8.3 Johnson & Johnson Anti-Infective Ophthalmic Product and Services
2.8.4 Johnson & Johnson Anti-Infective Ophthalmic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Johnson & Johnson Recent Developments/Updates
2.9 Thea pharmaceuticals
2.9.1 Thea pharmaceuticals Details
2.9.2 Thea pharmaceuticals Major Business
2.9.3 Thea pharmaceuticals Anti-Infective Ophthalmic Product and Services
2.9.4 Thea pharmaceuticals Anti-Infective Ophthalmic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Thea pharmaceuticals Recent Developments/Updates
2.10 URSAPHARM
2.10.1 URSAPHARM Details
2.10.2 URSAPHARM Major Business
2.10.3 URSAPHARM Anti-Infective Ophthalmic Product and Services
2.10.4 URSAPHARM Anti-Infective Ophthalmic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 URSAPHARM Recent Developments/Updates
2.11 SIMILASAN
2.11.1 SIMILASAN Details
2.11.2 SIMILASAN Major Business
2.11.3 SIMILASAN Anti-Infective Ophthalmic Product and Services
2.11.4 SIMILASAN Anti-Infective Ophthalmic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 SIMILASAN Recent Developments/Updates
2.12 Jianfeng Group
2.12.1 Jianfeng Group Details
2.12.2 Jianfeng Group Major Business
2.12.3 Jianfeng Group Anti-Infective Ophthalmic Product and Services
2.12.4 Jianfeng Group Anti-Infective Ophthalmic Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Jianfeng Group Recent Developments/Updates
3 Competitive Environment: Anti-Infective Ophthalmic by Manufacturer
3.1 Global Anti-Infective Ophthalmic Sales Quantity by Manufacturer (2018-2023)
3.2 Global Anti-Infective Ophthalmic Revenue by Manufacturer (2018-2023)
3.3 Global Anti-Infective Ophthalmic Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Anti-Infective Ophthalmic by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Anti-Infective Ophthalmic Manufacturer Market Share in 2022
3.4.2 Top 6 Anti-Infective Ophthalmic Manufacturer Market Share in 2022
3.5 Anti-Infective Ophthalmic Market: Overall Company Footprint Analysis
3.5.1 Anti-Infective Ophthalmic Market: Region Footprint
3.5.2 Anti-Infective Ophthalmic Market: Company Product Type Footprint
3.5.3 Anti-Infective Ophthalmic Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Anti-Infective Ophthalmic Market Size by Region
4.1.1 Global Anti-Infective Ophthalmic Sales Quantity by Region (2018-2029)
4.1.2 Global Anti-Infective Ophthalmic Consumption Value by Region (2018-2029)
4.1.3 Global Anti-Infective Ophthalmic Average Price by Region (2018-2029)
4.2 North America Anti-Infective Ophthalmic Consumption Value (2018-2029)
4.3 Europe Anti-Infective Ophthalmic Consumption Value (2018-2029)
4.4 Asia-Pacific Anti-Infective Ophthalmic Consumption Value (2018-2029)
4.5 South America Anti-Infective Ophthalmic Consumption Value (2018-2029)
4.6 Middle East and Africa Anti-Infective Ophthalmic Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Anti-Infective Ophthalmic Sales Quantity by Type (2018-2029)
5.2 Global Anti-Infective Ophthalmic Consumption Value by Type (2018-2029)
5.3 Global Anti-Infective Ophthalmic Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Anti-Infective Ophthalmic Sales Quantity by Application (2018-2029)
6.2 Global Anti-Infective Ophthalmic Consumption Value by Application (2018-2029)
6.3 Global Anti-Infective Ophthalmic Average Price by Application (2018-2029)
7 North America
7.1 North America Anti-Infective Ophthalmic Sales Quantity by Type (2018-2029)
7.2 North America Anti-Infective Ophthalmic Sales Quantity by Application (2018-2029)
7.3 North America Anti-Infective Ophthalmic Market Size by Country
7.3.1 North America Anti-Infective Ophthalmic Sales Quantity by Country (2018-2029)
7.3.2 North America Anti-Infective Ophthalmic Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Anti-Infective Ophthalmic Sales Quantity by Type (2018-2029)
8.2 Europe Anti-Infective Ophthalmic Sales Quantity by Application (2018-2029)
8.3 Europe Anti-Infective Ophthalmic Market Size by Country
8.3.1 Europe Anti-Infective Ophthalmic Sales Quantity by Country (2018-2029)
8.3.2 Europe Anti-Infective Ophthalmic Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Anti-Infective Ophthalmic Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Anti-Infective Ophthalmic Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Anti-Infective Ophthalmic Market Size by Region
9.3.1 Asia-Pacific Anti-Infective Ophthalmic Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Anti-Infective Ophthalmic Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Anti-Infective Ophthalmic Sales Quantity by Type (2018-2029)
10.2 South America Anti-Infective Ophthalmic Sales Quantity by Application (2018-2029)
10.3 South America Anti-Infective Ophthalmic Market Size by Country
10.3.1 South America Anti-Infective Ophthalmic Sales Quantity by Country (2018-2029)
10.3.2 South America Anti-Infective Ophthalmic Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Anti-Infective Ophthalmic Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Anti-Infective Ophthalmic Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Anti-Infective Ophthalmic Market Size by Country
11.3.1 Middle East & Africa Anti-Infective Ophthalmic Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Anti-Infective Ophthalmic Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Anti-Infective Ophthalmic Market Drivers
12.2 Anti-Infective Ophthalmic Market Restraints
12.3 Anti-Infective Ophthalmic Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Anti-Infective Ophthalmic and Key Manufacturers
13.2 Manufacturing Costs Percentage of Anti-Infective Ophthalmic
13.3 Anti-Infective Ophthalmic Production Process
13.4 Anti-Infective Ophthalmic Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Anti-Infective Ophthalmic Typical Distributors
14.3 Anti-Infective Ophthalmic Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Tables and Figures
List of Tables
Table 1. Global Anti-Infective Ophthalmic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Anti-Infective Ophthalmic Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Alcon Basic Information, Manufacturing Base and Competitors
Table 4. Alcon Major Business
Table 5. Alcon Anti-Infective Ophthalmic Product and Services
Table 6. Alcon Anti-Infective Ophthalmic Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Alcon Recent Developments/Updates
Table 8. AbbVie Basic Information, Manufacturing Base and Competitors
Table 9. AbbVie Major Business
Table 10. AbbVie Anti-Infective Ophthalmic Product and Services
Table 11. AbbVie Anti-Infective Ophthalmic Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. AbbVie Recent Developments/Updates
Table 13. Bausch Health Basic Information, Manufacturing Base and Competitors
Table 14. Bausch Health Major Business
Table 15. Bausch Health Anti-Infective Ophthalmic Product and Services
Table 16. Bausch Health Anti-Infective Ophthalmic Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Bausch Health Recent Developments/Updates
Table 18. Santen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 19. Santen Pharmaceutical Major Business
Table 20. Santen Pharmaceutical Anti-Infective Ophthalmic Product and Services
Table 21. Santen Pharmaceutical Anti-Infective Ophthalmic Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Santen Pharmaceutical Recent Developments/Updates
Table 23. Lupin Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 24. Lupin Pharmaceuticals Major Business
Table 25. Lupin Pharmaceuticals Anti-Infective Ophthalmic Product and Services
Table 26. Lupin Pharmaceuticals Anti-Infective Ophthalmic Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. Lupin Pharmaceuticals Recent Developments/Updates
Table 28. Apotex Basic Information, Manufacturing Base and Competitors
Table 29. Apotex Major Business
Table 30. Apotex Anti-Infective Ophthalmic Product and Services
Table 31. Apotex Anti-Infective Ophthalmic Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Apotex Recent Developments/Updates
Table 33. Akorn Basic Information, Manufacturing Base and Competitors
Table 34. Akorn Major Business
Table 35. Akorn Anti-Infective Ophthalmic Product and Services
Table 36. Akorn Anti-Infective Ophthalmic Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Akorn Recent Developments/Updates
Table 38. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 39. Johnson & Johnson Major Business
Table 40. Johnson & Johnson Anti-Infective Ophthalmic Product and Services
Table 41. Johnson & Johnson Anti-Infective Ophthalmic Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Johnson & Johnson Recent Developments/Updates
Table 43. Thea pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 44. Thea pharmaceuticals Major Business
Table 45. Thea pharmaceuticals Anti-Infective Ophthalmic Product and Services
Table 46. Thea pharmaceuticals Anti-Infective Ophthalmic Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Thea pharmaceuticals Recent Developments/Updates
Table 48. URSAPHARM Basic Information, Manufacturing Base and Competitors
Table 49. URSAPHARM Major Business
Table 50. URSAPHARM Anti-Infective Ophthalmic Product and Services
Table 51. URSAPHARM Anti-Infective Ophthalmic Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. URSAPHARM Recent Developments/Updates
Table 53. SIMILASAN Basic Information, Manufacturing Base and Competitors
Table 54. SIMILASAN Major Business
Table 55. SIMILASAN Anti-Infective Ophthalmic Product and Services
Table 56. SIMILASAN Anti-Infective Ophthalmic Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. SIMILASAN Recent Developments/Updates
Table 58. Jianfeng Group Basic Information, Manufacturing Base and Competitors
Table 59. Jianfeng Group Major Business
Table 60. Jianfeng Group Anti-Infective Ophthalmic Product and Services
Table 61. Jianfeng Group Anti-Infective Ophthalmic Sales Quantity (K Units), Average Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Jianfeng Group Recent Developments/Updates
Table 63. Global Anti-Infective Ophthalmic Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 64. Global Anti-Infective Ophthalmic Revenue by Manufacturer (2018-2023) & (USD Million)
Table 65. Global Anti-Infective Ophthalmic Average Price by Manufacturer (2018-2023) & (USD/Unit)
Table 66. Market Position of Manufacturers in Anti-Infective Ophthalmic, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 67. Head Office and Anti-Infective Ophthalmic Production Site of Key Manufacturer
Table 68. Anti-Infective Ophthalmic Market: Company Product Type Footprint
Table 69. Anti-Infective Ophthalmic Market: Company Product Application Footprint
Table 70. Anti-Infective Ophthalmic New Market Entrants and Barriers to Market Entry
Table 71. Anti-Infective Ophthalmic Mergers, Acquisition, Agreements, and Collaborations
Table 72. Global Anti-Infective Ophthalmic Sales Quantity by Region (2018-2023) & (K Units)
Table 73. Global Anti-Infective Ophthalmic Sales Quantity by Region (2024-2029) & (K Units)
Table 74. Global Anti-Infective Ophthalmic Consumption Value by Region (2018-2023) & (USD Million)
Table 75. Global Anti-Infective Ophthalmic Consumption Value by Region (2024-2029) & (USD Million)
Table 76. Global Anti-Infective Ophthalmic Average Price by Region (2018-2023) & (USD/Unit)
Table 77. Global Anti-Infective Ophthalmic Average Price by Region (2024-2029) & (USD/Unit)
Table 78. Global Anti-Infective Ophthalmic Sales Quantity by Type (2018-2023) & (K Units)
Table 79. Global Anti-Infective Ophthalmic Sales Quantity by Type (2024-2029) & (K Units)
Table 80. Global Anti-Infective Ophthalmic Consumption Value by Type (2018-2023) & (USD Million)
Table 81. Global Anti-Infective Ophthalmic Consumption Value by Type (2024-2029) & (USD Million)
Table 82. Global Anti-Infective Ophthalmic Average Price by Type (2018-2023) & (USD/Unit)
Table 83. Global Anti-Infective Ophthalmic Average Price by Type (2024-2029) & (USD/Unit)
Table 84. Global Anti-Infective Ophthalmic Sales Quantity by Application (2018-2023) & (K Units)
Table 85. Global Anti-Infective Ophthalmic Sales Quantity by Application (2024-2029) & (K Units)
Table 86. Global Anti-Infective Ophthalmic Consumption Value by Application (2018-2023) & (USD Million)
Table 87. Global Anti-Infective Ophthalmic Consumption Value by Application (2024-2029) & (USD Million)
Table 88. Global Anti-Infective Ophthalmic Average Price by Application (2018-2023) & (USD/Unit)
Table 89. Global Anti-Infective Ophthalmic Average Price by Application (2024-2029) & (USD/Unit)
Table 90. North America Anti-Infective Ophthalmic Sales Quantity by Type (2018-2023) & (K Units)
Table 91. North America Anti-Infective Ophthalmic Sales Quantity by Type (2024-2029) & (K Units)
Table 92. North America Anti-Infective Ophthalmic Sales Quantity by Application (2018-2023) & (K Units)
Table 93. North America Anti-Infective Ophthalmic Sales Quantity by Application (2024-2029) & (K Units)
Table 94. North America Anti-Infective Ophthalmic Sales Quantity by Country (2018-2023) & (K Units)
Table 95. North America Anti-Infective Ophthalmic Sales Quantity by Country (2024-2029) & (K Units)
Table 96. North America Anti-Infective Ophthalmic Consumption Value by Country (2018-2023) & (USD Million)
Table 97. North America Anti-Infective Ophthalmic Consumption Value by Country (2024-2029) & (USD Million)
Table 98. Europe Anti-Infective Ophthalmic Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Europe Anti-Infective Ophthalmic Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Europe Anti-Infective Ophthalmic Sales Quantity by Application (2018-2023) & (K Units)
Table 101. Europe Anti-Infective Ophthalmic Sales Quantity by Application (2024-2029) & (K Units)
Table 102. Europe Anti-Infective Ophthalmic Sales Quantity by Country (2018-2023) & (K Units)
Table 103. Europe Anti-Infective Ophthalmic Sales Quantity by Country (2024-2029) & (K Units)
Table 104. Europe Anti-Infective Ophthalmic Consumption Value by Country (2018-2023) & (USD Million)
Table 105. Europe Anti-Infective Ophthalmic Consumption Value by Country (2024-2029) & (USD Million)
Table 106. Asia-Pacific Anti-Infective Ophthalmic Sales Quantity by Type (2018-2023) & (K Units)
Table 107. Asia-Pacific Anti-Infective Ophthalmic Sales Quantity by Type (2024-2029) & (K Units)
Table 108. Asia-Pacific Anti-Infective Ophthalmic Sales Quantity by Application (2018-2023) & (K Units)
Table 109. Asia-Pacific Anti-Infective Ophthalmic Sales Quantity by Application (2024-2029) & (K Units)
Table 110. Asia-Pacific Anti-Infective Ophthalmic Sales Quantity by Region (2018-2023) & (K Units)
Table 111. Asia-Pacific Anti-Infective Ophthalmic Sales Quantity by Region (2024-2029) & (K Units)
Table 112. Asia-Pacific Anti-Infective Ophthalmic Consumption Value by Region (2018-2023) & (USD Million)
Table 113. Asia-Pacific Anti-Infective Ophthalmic Consumption Value by Region (2024-2029) & (USD Million)
Table 114. South America Anti-Infective Ophthalmic Sales Quantity by Type (2018-2023) & (K Units)
Table 115. South America Anti-Infective Ophthalmic Sales Quantity by Type (2024-2029) & (K Units)
Table 116. South America Anti-Infective Ophthalmic Sales Quantity by Application (2018-2023) & (K Units)
Table 117. South America Anti-Infective Ophthalmic Sales Quantity by Application (2024-2029) & (K Units)
Table 118. South America Anti-Infective Ophthalmic Sales Quantity by Country (2018-2023) & (K Units)
Table 119. South America Anti-Infective Ophthalmic Sales Quantity by Country (2024-2029) & (K Units)
Table 120. South America Anti-Infective Ophthalmic Consumption Value by Country (2018-2023) & (USD Million)
Table 121. South America Anti-Infective Ophthalmic Consumption Value by Country (2024-2029) & (USD Million)
Table 122. Middle East & Africa Anti-Infective Ophthalmic Sales Quantity by Type (2018-2023) & (K Units)
Table 123. Middle East & Africa Anti-Infective Ophthalmic Sales Quantity by Type (2024-2029) & (K Units)
Table 124. Middle East & Africa Anti-Infective Ophthalmic Sales Quantity by Application (2018-2023) & (K Units)
Table 125. Middle East & Africa Anti-Infective Ophthalmic Sales Quantity by Application (2024-2029) & (K Units)
Table 126. Middle East & Africa Anti-Infective Ophthalmic Sales Quantity by Region (2018-2023) & (K Units)
Table 127. Middle East & Africa Anti-Infective Ophthalmic Sales Quantity by Region (2024-2029) & (K Units)
Table 128. Middle East & Africa Anti-Infective Ophthalmic Consumption Value by Region (2018-2023) & (USD Million)
Table 129. Middle East & Africa Anti-Infective Ophthalmic Consumption Value by Region (2024-2029) & (USD Million)
Table 130. Anti-Infective Ophthalmic Raw Material
Table 131. Key Manufacturers of Anti-Infective Ophthalmic Raw Materials
Table 132. Anti-Infective Ophthalmic Typical Distributors
Table 133. Anti-Infective Ophthalmic Typical Customers
List of Figures
Figure 1. Anti-Infective Ophthalmic Picture
Figure 2. Global Anti-Infective Ophthalmic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Anti-Infective Ophthalmic Consumption Value Market Share by Type in 2022
Figure 4. Eyedrops Examples
Figure 5. Gels Examples
Figure 6. Ointments Examples
Figure 7. Other Examples
Figure 8. Global Anti-Infective Ophthalmic Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 9. Global Anti-Infective Ophthalmic Consumption Value Market Share by Application in 2022
Figure 10. Hospital Examples
Figure 11. Retail Pharmacy Examples
Figure 12. Others Examples
Figure 13. Global Anti-Infective Ophthalmic Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Anti-Infective Ophthalmic Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Anti-Infective Ophthalmic Sales Quantity (2018-2029) & (K Units)
Figure 16. Global Anti-Infective Ophthalmic Average Price (2018-2029) & (USD/Unit)
Figure 17. Global Anti-Infective Ophthalmic Sales Quantity Market Share by Manufacturer in 2022
Figure 18. Global Anti-Infective Ophthalmic Consumption Value Market Share by Manufacturer in 2022
Figure 19. Producer Shipments of Anti-Infective Ophthalmic by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 20. Top 3 Anti-Infective Ophthalmic Manufacturer (Consumption Value) Market Share in 2022
Figure 21. Top 6 Anti-Infective Ophthalmic Manufacturer (Consumption Value) Market Share in 2022
Figure 22. Global Anti-Infective Ophthalmic Sales Quantity Market Share by Region (2018-2029)
Figure 23. Global Anti-Infective Ophthalmic Consumption Value Market Share by Region (2018-2029)
Figure 24. North America Anti-Infective Ophthalmic Consumption Value (2018-2029) & (USD Million)
Figure 25. Europe Anti-Infective Ophthalmic Consumption Value (2018-2029) & (USD Million)
Figure 26. Asia-Pacific Anti-Infective Ophthalmic Consumption Value (2018-2029) & (USD Million)
Figure 27. South America Anti-Infective Ophthalmic Consumption Value (2018-2029) & (USD Million)
Figure 28. Middle East & Africa Anti-Infective Ophthalmic Consumption Value (2018-2029) & (USD Million)
Figure 29. Global Anti-Infective Ophthalmic Sales Quantity Market Share by Type (2018-2029)
Figure 30. Global Anti-Infective Ophthalmic Consumption Value Market Share by Type (2018-2029)
Figure 31. Global Anti-Infective Ophthalmic Average Price by Type (2018-2029) & (USD/Unit)
Figure 32. Global Anti-Infective Ophthalmic Sales Quantity Market Share by Application (2018-2029)
Figure 33. Global Anti-Infective Ophthalmic Consumption Value Market Share by Application (2018-2029)
Figure 34. Global Anti-Infective Ophthalmic Average Price by Application (2018-2029) & (USD/Unit)
Figure 35. North America Anti-Infective Ophthalmic Sales Quantity Market Share by Type (2018-2029)
Figure 36. North America Anti-Infective Ophthalmic Sales Quantity Market Share by Application (2018-2029)
Figure 37. North America Anti-Infective Ophthalmic Sales Quantity Market Share by Country (2018-2029)
Figure 38. North America Anti-Infective Ophthalmic Consumption Value Market Share by Country (2018-2029)
Figure 39. United States Anti-Infective Ophthalmic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Canada Anti-Infective Ophthalmic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 41. Mexico Anti-Infective Ophthalmic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 42. Europe Anti-Infective Ophthalmic Sales Quantity Market Share by Type (2018-2029)
Figure 43. Europe Anti-Infective Ophthalmic Sales Quantity Market Share by Application (2018-2029)
Figure 44. Europe Anti-Infective Ophthalmic Sales Quantity Market Share by Country (2018-2029)
Figure 45. Europe Anti-Infective Ophthalmic Consumption Value Market Share by Country (2018-2029)
Figure 46. Germany Anti-Infective Ophthalmic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. France Anti-Infective Ophthalmic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. United Kingdom Anti-Infective Ophthalmic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Russia Anti-Infective Ophthalmic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 50. Italy Anti-Infective Ophthalmic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 51. Asia-Pacific Anti-Infective Ophthalmic Sales Quantity Market Share by Type (2018-2029)
Figure 52. Asia-Pacific Anti-Infective Ophthalmic Sales Quantity Market Share by Application (2018-2029)
Figure 53. Asia-Pacific Anti-Infective Ophthalmic Sales Quantity Market Share by Region (2018-2029)
Figure 54. Asia-Pacific Anti-Infective Ophthalmic Consumption Value Market Share by Region (2018-2029)
Figure 55. China Anti-Infective Ophthalmic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Japan Anti-Infective Ophthalmic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Korea Anti-Infective Ophthalmic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. India Anti-Infective Ophthalmic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. Southeast Asia Anti-Infective Ophthalmic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 60. Australia Anti-Infective Ophthalmic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 61. South America Anti-Infective Ophthalmic Sales Quantity Market Share by Type (2018-2029)
Figure 62. South America Anti-Infective Ophthalmic Sales Quantity Market Share by Application (2018-2029)
Figure 63. South America Anti-Infective Ophthalmic Sales Quantity Market Share by Country (2018-2029)
Figure 64. South America Anti-Infective Ophthalmic Consumption Value Market Share by Country (2018-2029)
Figure 65. Brazil Anti-Infective Ophthalmic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 66. Argentina Anti-Infective Ophthalmic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 67. Middle East & Africa Anti-Infective Ophthalmic Sales Quantity Market Share by Type (2018-2029)
Figure 68. Middle East & Africa Anti-Infective Ophthalmic Sales Quantity Market Share by Application (2018-2029)
Figure 69. Middle East & Africa Anti-Infective Ophthalmic Sales Quantity Market Share by Region (2018-2029)
Figure 70. Middle East & Africa Anti-Infective Ophthalmic Consumption Value Market Share by Region (2018-2029)
Figure 71. Turkey Anti-Infective Ophthalmic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Egypt Anti-Infective Ophthalmic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Saudi Arabia Anti-Infective Ophthalmic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 74. South Africa Anti-Infective Ophthalmic Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 75. Anti-Infective Ophthalmic Market Drivers
Figure 76. Anti-Infective Ophthalmic Market Restraints
Figure 77. Anti-Infective Ophthalmic Market Trends
Figure 78. Porters Five Forces Analysis
Figure 79. Manufacturing Cost Structure Analysis of Anti-Infective Ophthalmic in 2022
Figure 80. Manufacturing Process Analysis of Anti-Infective Ophthalmic
Figure 81. Anti-Infective Ophthalmic Industrial Chain
Figure 82. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 83. Direct Channel Pros & Cons
Figure 84. Indirect Channel Pros & Cons
Figure 85. Methodology
Figure 86. Research Process and Data Source
Reason to Buy
- Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
- Highlights key business priorities in order to assist companies to realign their business strategies
- The segment that is expected to dominate the Pharma & Healthcare Market
- Regions that are expected to witness the fastest growth during the forecast period
- Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets